Trials / Completed
CompletedNCT01970917
Effect of Olixia Pure® Eye Drops on Tear Film Thickness in Healthy Subjects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Dry eye syndrome (DES) is a common ocular disease, especially in the elderly population. Despite many treatment approaches, instillation of topical lubricants remains the mainstay of therapy. However, most of the topical lubricants available are not very well characterized and data about efficacy is sparse. The aim of the present project is to investigate the effect of topically administered Olixia pure® eye drops on tear film thickness in healthy subjects. Tear film thickness will be determined using ultra high-resolution optical coherence tomography (OCT). Measurements will be performed before instillation of the eye drops and every 10 minutes after instillation for one hour. One eye will receive Olixia pure® eye drops, the fellow eye will receive physiologic saline solution as placebo control. The study eye will be chosen randomly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Olixia pure eye drops | |
| DEVICE | Placebo | 0.9% physiological saline solution |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2013-10-28
- Last updated
- 2013-11-27
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01970917. Inclusion in this directory is not an endorsement.